Group B streptococcus and respiratory syncytial virus are leading causes of infant morbidity
and mortality worldwide. No licensed vaccines are available for either disease, but vaccines …

Group B Streptococcus (GBS) is a leading cause of neonatal bacterial infections in
developed countries. Early-onset disease (EOD) occurs at day 0–6 and late-onset disease …

Objectives To explore factors influencing the likelihood of antenatal vaccine acceptance of
both routine UK antenatal vaccines (influenza and pertussis) and a hypothetical group B …

ABSTRACT Group B Streptococcus (GBS) vaccines, designed to be given to pregnant
women, are in clinical trials. There is an opportunity to conduct preparatory research now to …

Introduction Maternal vaccination is increasingly part of antenatal care in the UK and
worldwide. Trials of Group B streptococcus vaccines are ongoing. This study investigated …

For those with evidence of colonisation in the current pregnancy or in previous pregnancies,
the perinatal risks associated with preterm delivery at less than 34+ 0 weeks of gestation are …

Pregnancy and early infancy are periods of relative immune suppression and increased
vulnerability to infection. In these circumstances infections are associated with high …

Background The prevention of mother to child transmission of HIV has resulted in reduced
burden of pediatric HIV-infection, but the prevalence of maternal HIV infection remains high …

Streptococcus agalactiae is a major pathogenic bacterium causing perinatal infections in
humans. In the present study, a novel real-time fluorescence loop-mediated isothermal …

Abstract Objective Group B Streptococcus (GBS) causes significant infant morbidity and
mortality. Promising GBS vaccines are currently in clinical trials. Because GBS vaccines …